SCHEMBL15026353

SCHEMBL15026353

O=C1c2ccccc2C(=O)c2oc(S(=O)(=O)c3ccc(F)cc3)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.44
▸ STAT3 P40763 2/20 0.44
▸ USP1 O94782 1/20 0.43
▸ USP19 O94966 1/20 0.43
▸ UCHL3 P15374 1/20 0.43
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ PTGS2 P35354 2/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ PKLR P30613 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ SENP8 Q96LD8 1/20 0.38
▸ SENP7 Q9BQF6 1/20 0.38
▸ SENP6 Q9GZR1 1/20 0.38
▸ PGAM1 P18669 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL45702 0.90 MAPT (0.38) ALDH1A1STAT3USP1USP19UCHL3
SCHEMBL15024250 0.85 ALDH1A1 (0.48) ALDH1A1STAT3MEN1KMT2APKLR
SCHEMBL15024455 0.82 TLR9 (0.38) ALDH1A1MEN1KMT2APTGS2MAPT
SCHEMBL45695 0.74 STAT3 (0.56) ALDH1A1STAT3USP1USP19MEN1
SCHEMBL45822 0.74 STAT3 (0.42) ALDH1A1STAT3USP1USP19UCHL3
SCHEMBL45647 0.74 STAT3 (0.47) ALDH1A1STAT3USP1USP19UCHL3
SCHEMBL16167166 0.72 STAT3 (0.56) ALDH1A1STAT3USP1USP19UCHL3
SCHEMBL45711 0.72 PTGS2 (0.39) ALDH1A1STAT3PTGS2PTGS1
SCHEMBL15026352 0.70 USP8 (0.35) ALDH1A1STAT3USP1USP19UCHL3
Anthraquinone SCHEMBL28557258 0.69 SMN1; SMN2 (0.52) ALDH1A1MEN1KMT2APTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871802-B2 Naphthoquinones for disease therapies ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. (CN) 2014-10-28 — — US disclosed
US-20130150437-A1 NAPHTHOQUINONES FOR DISEASE THERAPIES ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. (CN) 2013-06-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150437-A1 NAPHTHOQUINONES FOR DISEASE THERAPIES NQO1, NME2, CYP27B1 ALDH1A1 282/4885STAT3 1764/4885USP1 4540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback